Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
The innovation-powered content management platform to produce and distribute high quality digital content
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Join upcoming conversations with the industry’s leading experts and watch recordings of past events hosted by Viseven.
When faced with life-or-death treatment decisions, healthcare stakeholders need more than clinical data alone — they need a complete picture of both effectiveness and value. Health Economics and Outcomes Research (HEOR) delivers this by uncovering the true impact of therapies on patient outcomes, healthcare costs, and quality of life. For the pharmaceutical industry, HEOR isn’t […]
When you invest months into a pharmaceutical marketing campaign — carefully crafting messaging, selecting the right channels, analyzing audience insights, and aligning strategies with compliance requirements — you want it to drive meaningful engagement and deliver measurable results. But what if, despite all that effort, your campaign falls flat? Low response rates, disengaged healthcare providers, […]
How did we reach a point where surgeons rely on robots and where patients monitor their health 24/7 without setting foot in a doctor’s office? What once felt like science fiction has become an everyday reality for patients, healthcare providers (HCPs), and hospitals. Pressing challenges drove the adoption of the Internet of Medical Things (IoMT). […]
